SNHG17 may promote the development of cancer through various molecular mechanisms, such as up-regulating FOXA1, sponging miR-328-3p, targeting microRNA-375-3p, inhibiting P15 and P16 (45, 59, 63, 64). This evidence concerns the gene FOXA1 and cancer.